These pathways include but are not limited to HIF-1α/VEGF/VEGFR2/PI3K/AKT, Wnt/β-catenin, JNK1/STAT3, and MAPK/AP-1, which may provide some new active ingredients or targets for future cancer treatment. This evidence concerns the gene VEGFA and cancer.